$3.91 Billion is the total value of Matrix Capital Management Company, LP's 22 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 36.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ADPT | Sell | ADAPTIVE BIOTECHNOLOGIES COR | $419,897,000 | -19.0% | 15,115,090 | -12.8% | 10.74% | -2.8% |
| CRM | Sell | SALESFORCE COM INC | $377,560,000 | -53.7% | 2,622,309 | -47.8% | 9.65% | -44.4% |
| AMZN | Sell | AMAZON COM INC | $201,016,000 | +4.5% | 103,100 | -1.0% | 5.14% | +25.5% |
| DOCU | Sell | DOCUSIGN INC | $124,293,000 | -3.7% | 1,345,166 | -22.7% | 3.18% | +15.7% |
| WDAY | Sell | WORKDAY INCcl a | $106,780,000 | -23.6% | 820,000 | -3.5% | 2.73% | -8.3% |
| CARG | Sell | CARGURUS INC | $72,200,000 | -61.9% | 3,812,048 | -29.3% | 1.85% | -54.3% |
| FB | Sell | FACEBOOK INCcl a | $43,718,000 | -79.7% | 262,100 | -75.0% | 1.12% | -75.6% |
| SQ | Exit | SQUARE INCcl a | $0 | – | -95,700 | -100.0% | -0.13% | – |
| PTC | Exit | PTC INC | $0 | – | -582,600 | -100.0% | -0.93% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -1,934,347 | -100.0% | -3.60% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -1,598,352 | -100.0% | -3.89% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TRANSDIGM GROUP INC | 42 | Q3 2023 | 13.3% |
| WORKDAY INC | 42 | Q3 2023 | 19.7% |
| NETFLIX INC | 37 | Q2 2022 | 26.1% |
| NEW RELIC INC | 29 | Q1 2022 | 7.8% |
| DAVITA INC | 26 | Q3 2019 | 6.1% |
| ADAPTIMMUNE THERAPEUTICS PLC | 26 | Q3 2023 | 6.8% |
| SALESFORCE INC | 23 | Q3 2022 | 18.4% |
| CONSTELLATION BRANDS INC | 23 | Q2 2019 | 5.7% |
| AMAZON COM INC | 21 | Q3 2023 | 11.2% |
| TABLEAU SOFTWARE INC | 20 | Q2 2019 | 15.2% |
View Matrix Capital Management Company, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adaptimmune Therapeutics PLC | July 10, 2023 | 233,845,110 | 17.3% |
| Zentalis Pharmaceuticals, Inc. | June 20, 2023 | 13,959,973 | 19.8% |
| ForgeRock, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| NEW RELIC, INC.Sold out | February 13, 2023 | 0 | 0.0% |
| Perimeter Solutions, SA | February 13, 2023 | 8,587,500 | 5.4% |
| Aura Biosciences, Inc. | December 07, 2022 | 5,362,870 | 14.5% |
| Adaptive Biotechnologies Corp | February 14, 2022 | 11,572,590 | 8.2% |
| BigCommerce Holdings, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| CarGurus, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Trillium Therapeutics Inc.Sold out | February 14, 2020 | 0 | 0.0% |
View Matrix Capital Management Company, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-11-09 |
| SC 13D/A | 2023-11-09 |
| 13F-HR | 2023-08-14 |
| SC 13G/A | 2023-07-10 |
| 4 | 2023-06-20 |
| SC 13D/A | 2023-06-20 |
| 13F-HR | 2023-05-15 |
View Matrix Capital Management Company, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.